Applied since the start of the coronavirus pandemic, the therapeutic protocol, based on hydroxychloroquine, to which patients suffering from Covid-19 have been subjected, has given complete satisfaction. Indeed, according to specialists who took stock of the PSA treatment this Saturday, April 25, hydroxychloroquine has proven its effectiveness.
Dr. Mohamed Yousfi, head of the infectious diseases department at Boufarik hospital ( Blida ), affirmed supporting figures that the treatment is effective.
He indicated that half of the patients admitted since March 23, 2020 at this establishment, had left the hospital, completely cured after being treated either with hydroxychloroquine or antivirals in other cases.
Mohamed Yousfi specifies that “there are only a few patients excluded from this therapeutic protocol, like patients suffering from cardiovascular diseases and those who have not tolerated this treatment. The latter were put on antivirals, used in the treatment of HIV infections and which have given very satisfactory results ”.
As for Prof. Nassima Achour, head of the infectious diseases department at the El-Hadi Flici (ex-El-Kettar) specialized hospital establishment (EHS) in Algiers , she confirms his colleague’s observation.
She claims that hydroxychloroquine has been shown to be “almost completely effective”. Nassima Achour adds that the state of health of patients subjected to this treatment is experiencing a positive development day by day.Prof. Nassima Achour, head of the infectious diseases department at the El-Hadi Flici (ex-El-Kettar)
In addition, the Director General of the National Institute of Public Health (INSP), Prof. Lyes Rehal ensures that the therapeutic protocol based on hydroxychloroquine has shown its effectiveness in most patients to whom it has been administered in Algeria .
He specifies that 69.4% of the 5,000 patients treated, from March 24 to date, have been subjected to treatment with hydroxychloroquine for a maximum period of 10 days. The professor indicates that “21.3% of the aforementioned sample received hydroxychloroquine treatment for a period ranging from 5 to 6 days and only 1.8% received this treatment for a period ranging from one (01) day to 5 days.”